1373503-54-8 Usage
General Description
2-(1-(tert-butoxycarbonyl)-3,3-difluoropiperidin-4-yl)acetic acid, also known as Boc-Difluoro-piperidin-4-yl-acetic acid, is a chemical compound used in the synthesis of pharmaceuticals and biochemical research. The compound consists of a piperidine ring with two fluorine atoms and a tert-butoxycarbonyl group attached to the nitrogen atom. It is commonly used as a starting material in the production of various pharmaceutical drugs and as a building block in organic synthesis. The compound's structure and reactivity make it valuable in the development of new drugs and medicinal products. Additionally, the chemical's potential for biological activity and pharmaceutical applications make it an important compound in the field of medicinal chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1373503-54-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,3,5,0 and 3 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1373503-54:
(9*1)+(8*3)+(7*7)+(6*3)+(5*5)+(4*0)+(3*3)+(2*5)+(1*4)=148
148 % 10 = 8
So 1373503-54-8 is a valid CAS Registry Number.
1373503-54-8Relevant articles and documents
TLR7/8 ANTAGONISTS AND USES THEREOF
-
, (2019/02/05)
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.
3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS
-
, (2016/12/22)
Disclosed are chemical entities of Formula (I), wherein R1 and Z are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of Formula (I), and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of Formula (I).
